• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Lifecore Biomedical, Inc. - Common Stock (NQ: LFCR )

    5.075 -0.015 (-0.29%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Sep 17, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 123,205
    Open 5.090
    Bid (Size) 5.070 (1)
    Ask (Size) 5.080 (8)
    Prev. Close 5.090
    Today's Range 5.050 - 5.260
    52wk Range 3.679 - 8.900
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    LIFECORE BIOMEDICAL, INC. (NASDAQ: LFCR) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Lifecore Biomedical, Inc. Investors of Upcoming Deadline
    From Bernstein Liebhard LLP
    Via GlobeNewswire
    Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lifecore, Spire Global, Oddity Tech, and Arbor Realty and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire

    Performance

    YTD
    -20.45%
    -20.45%
    1 Month
    -9.37%
    -9.37%
    3 Month
    -1.46%
    -1.46%
    6 Month
    -29.32%
    -29.32%
    1 Year
    -37.81%
    -37.81%

    More News

    Read More
    Faruqi & Faruqi Reminds Lifecore Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 27, 2024 - LFCR
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    Lifecore Biomedical to Participate in Craig-Hallum Bioprocessing Conference
    From Lifecore Biomedical, Inc.
    Via GlobeNewswire
    Lifecore Biomedical Regains Compliance with Nasdaq Listing Requirements
    From Lifecore Biomedical, Inc.
    Via GlobeNewswire
    Lead Plaintiff Deadline Quickly Approaching in Lifecore Biomedical, Inc. (LFCR) Class Action – Shareholders Should Contact Robbins LLP for Information
    From Robbins LLP
    Via GlobeNewswire
    Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lifecore, Spire Global, Oddity Tech, and Arbor Realty and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Lifecore Biomedical Appoints Brikkelle Thompson as Senior Vice President of Human Resources
    From Lifecore Biomedical, Inc.
    Via GlobeNewswire
    LIFECORE BIOMEDICAL, INC. (NASDAQ: LFCR) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Lifecore Biomedical, Inc. Investors of Upcoming Deadline
    From Bernstein Liebhard LLP
    Via GlobeNewswire
    Lifecore Biomedical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Lifecore Biomedical, Inc.
    Via GlobeNewswire
    ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    Lifecore Biomedical to Participate in 17th Annual Barrington Research Virtual Fall Investment Conference
    From Lifecore Biomedical, Inc.
    Via GlobeNewswire
    Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lifecore, Spire Global, Oddity Tech, and Arbor Realty and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    LIFECORE BIOMEDICAL, INC. (NASDAQ: LFCR) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Lifecore Biomedical, Inc. Investors of Upcoming Deadline
    From Bernstein Liebhard LLP
    Via GlobeNewswire
    Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lifecore, Spire Global, Oddity Tech, and Arbor Realty and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    Lifecore Biomedical Announces Chief Financial Officer Transition
    From Lifecore Biomedical, Inc.
    Via GlobeNewswire
    Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lifecore, Seritage, Oddity Tech, and Arbor Realty and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Lifecore Biomedical Reports Fourth Quarter and Fiscal Year End 2024 Financial Results and Provides Corporate Update
    From Lifecore Biomedical, Inc.
    Via GlobeNewswire
    LIFECORE BIOMEDICAL, INC. (NASDAQ: LFCR) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Lifecore Biomedical, Inc. Investors of Upcoming Deadline
    From Bernstein Liebhard LLP
    Via GlobeNewswire
    Kirby McInerney LLP Reminds Lifecore Biomedical, Inc. (LFCR) Investors of Class Action Filing and Encourages Investors to Contact the Firm
    From Kirby McInerney LLP
    Via Business Wire
    Pending Lead Plaintiff Deadline in the LFCR Class Action: Robbins LLP Reminds Stockholders With Large Losses of Lifecore Biomedical, Inc. to Seek Counsel
    From Robbins LLP
    Via GlobeNewswire
    SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lifecore, Seritage, Oddity Tech, and Arbor Realty and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.